ODP Early-Stage Investigator Lecture Nomination and Selection Process
The Office of Disease Prevention (ODP) is pleased to announce the 2019 call for nominations for the 3rd ODP Early-Stage Investigator Lecture (ESIL). The award is given to an early-career prevention scientist who has made significant research contributions, but who has not yet successfully competed for an R01 or R01 equivalent NIH research grant.
2019 Lecture Details
Deadline for Submissions: November 2, 2018
Winner Notified: January 15, 2019
Lecture Presentation: March 27, 2019
The award winner will be invited, with all travel expenses covered, to give a lecture at the NIH on Wednesday, March 27, 2019. The awardee will also be offered an opportunity for professional networking with NIH program directors and scientists during a 2-day visit.
At the time of the nomination due date (November 2, 2018), the candidate must meet the NIH’s definition of an early-stage investigator (ESI). This means the candidate:
- Completed a terminal research degree within the last 10 years
- Has not yet been awarded an R01 or R01 equivalent NIH research grant.
(See list of NIH grants that an investigator can hold and still be considered an ESI)
Federal government employees, including fellows and contractors, are not eligible.
Nominees should have:
- Innovative and significant research accomplishments in applied prevention research in humans in areas that are relevant to the ODP’s mission
- Evidence of highly collaborative research projects, especially those that bridge disciplines to offer new approaches and ways of thinking in disease prevention research
Priority will be given to nominees conducting applied prevention research on any of the following common risk factors for death and disability in the United States: tobacco, overweight/obesity, poor diet, physical inactivity, alcohol misuse, drug abuse, risky sexual behavior, injury and violence, infectious disease, and environmental health.
ODP will also consider nominations in the areas of reducing health disparities, advancing research on methods and measurement, or disease screening.
Nomination packages may be submitted by the nominee or the nominee’s mentor. Nomination packages must be a single PDF file that includes:
- NIH Biosketch including a link (URL) to the nominee’s My Bibliography in PubMed
- If you do not have a My Bibliography in PubMed, refer to these simple step-by-step instructions to save your citations in PubMed to a “My Bibliography”
- Use the URL that PubMed automatically generates when you change your “My Bibliography” sharing setting to public
- One letter of nomination (1,000 words or less) from a mentor or colleague familiar with the nominee’s work, addressing the nominee’s innovative contribution to the field of prevention research and his/her cross-cutting and collaborative nature of his/her research. This letter should demonstrate the lasting significance and impact of the nominee’s work to date.
- A PDF of a key, peer-reviewed article published in the past 12-month period, which is first-authored by the nominee. If in press, please provide a Word version of the accepted paper and the letter of acceptance from journal.
After compiling all of the above elements into a single PDF file, attach the PDF to an email, and send it to firstname.lastname@example.org with the subject line header “2019 ESIL Nomination” no later than 11:59 p.m. on November 2, 2018.
Review and Selection Process
The review process consists of two stages.
- Stage 1: The ODP assembles review panels composed of NIH staff with relevant expertise (informed by the nominations received). These content-area specific panels perform the initial review of the nomination packages and make recommendations to the ODP Director.
- Stage 2: The ODP Director reviews the recommendations and selects the finalists and the winner(s).